Gilead Sciences | 유동 부채

Current Liabilities 변화 날짜
AbbVie USD 41.52B 6.75B 2024-03
Agios Pharmaceuticals USD 51.69M 16.26M 2024-03
ALKERMES USD 458.98M 56.7M 2024-03
Alnylam Pharmaceuticals USD 941.71M 26.08M 2024-03
Amgen USD 19.71B 1.32B 2024-03
Biogen USD 3.22B 211.5M 2024-03
BioMarin Pharmaceutical USD 1.09B 89.12M 2024-03
Bristol-Myers Squibb USD 25.82B 2.36B 2024-03
Eli Lilly USD 18.6B 3.4B 2024-03
Gilead Sciences USD 13.02B 1.74B 2024-03
GlaxoSmithKline GBP 19.85B 1.22B 2024-03
Glaxosmithkline GBP 19.85B 1.22B 2024-03
Incyte USD 1.4B 156.07M 2024-03
J&J USD 48.72B 4.36B 2024-03
Merck USD 25.1B 2.01B 2024-03
Moderna USD 2.38B 635M 2024-03
Neurocrine Biosciences USD 712.9M 21.3M 2024-03
Novartis USD 29.29B 2.9B 2024-03
Pfizer USD 40.5B 9.36B 2024-03
PTC Therapeutics USD 574.55M 28.55M 2024-03
Regeneron Pharmaceuticals USD 3.58B 823.3M 2024-03
Sarepta Therapeutics USD 608.71M 157.97M 2024-03
United Therapeutics USD 860.6M 56.2M 2024-03
Vertex Pharmaceuticals USD 3.8B 196.5M 2024-03



Gilead Sciences 유동 부채 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Jun 2024.